A pharmaceutical company that markets Sucraid® (sacrosidase), an FDA-approved enzyme replacement therapy for sucrase deficiency due to CSID.

Case Studies

Showing 1 Success Stories about Software and Services used by QOL Medical

QOL Medical enhances CSID education for healthcare providers with Rizco’s Sucraid® eDetail

No matching case studies